The German government's global health strategy – a strategy also to support research and development for neglected diseases?

Fehr A, Razum O (2014)
Global Health Action 7: 1-3.

Download
OA
Journal Article | Published | English
Author
;
Abstract
Neglected tropical infectious diseases as well as rare diseases are characterized by structural research and development (R&D) deficits. The market fails for these disease groups. Consequently, to meet public health and individual patient needs, political decision makers have to develop strategies at national and international levels to make up for this R&D deficit. The German government recently published its first global health strategy. The strategy underlines the German government’s commitment to strengthening global health governance. We find, however, that the strategy lacks behind the international public health endeavors for neglected diseases. It fails to make reference to the ongoing debate on a global health agreement. Neither does it outline a comprehensive national strategy to promote R&D into neglected diseases, which would integrate existing R&D activities in Germany and link up to the international debate on sustainable, needs-based R&D and affordable access. This despite the fact that only recently, in a consensus-building process, a National Plan of Action for rare diseases was successfully developed in Germany which could serve as a blueprint for a similar course of action for neglected diseases. We recommend that, without delay, a structured process be initiated in Germany to explore all options to promote R&D for neglected diseases, including a global health agreement.
Publishing Year
ISSN
eISSN
Financial disclosure
Article Processing Charge funded by the Deutsche Forschungsgemeinschaft and the Open Access Publication Fund of Bielefeld University.
PUB-ID

Cite this

Fehr A, Razum O. The German government's global health strategy – a strategy also to support research and development for neglected diseases? Global Health Action. 2014;7:1-3.
Fehr, A., & Razum, O. (2014). The German government's global health strategy – a strategy also to support research and development for neglected diseases? Global Health Action, 7, 1-3.
Fehr, A., and Razum, O. (2014). The German government's global health strategy – a strategy also to support research and development for neglected diseases? Global Health Action 7, 1-3.
Fehr, A., & Razum, O., 2014. The German government's global health strategy – a strategy also to support research and development for neglected diseases? Global Health Action, 7, p 1-3.
A. Fehr and O. Razum, “The German government's global health strategy – a strategy also to support research and development for neglected diseases?”, Global Health Action, vol. 7, 2014, pp. 1-3.
Fehr, A., Razum, O.: The German government's global health strategy – a strategy also to support research and development for neglected diseases? Global Health Action. 7, 1-3 (2014).
Fehr, Angela, and Razum, Oliver. “The German government's global health strategy – a strategy also to support research and development for neglected diseases?”. Global Health Action 7 (2014): 1-3.
Main File(s)
Access Level
OA Open Access
Last Uploaded
2014-08-14 14:35:50

This data publication is cited in the following publications:
This publication cites the following data publications:

28 References

Data provided by Europe PubMed Central.

Nationaler Aktionsplan für Menschen mit Seltenen Erkrankungen
AUTHOR UNKNOWN, 2013
Expert Delphi survey on research and development into drugs for neglected diseases.
Fehr A, Thurmann P, Razum O., BMC Health Serv Res 11(), 2011
PMID: 22087801
G-Finder global funding of innovation for neglected diseases
AUTHOR UNKNOWN, 2013

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 25079287
PubMed | Europe PMC

Search this title in

Google Scholar